1-Hydroxybenzotriazole → 1'-{[4-(2-Methyl-1,3-oxazol-5-yl)-3,5-dimethoxyphenyl]carbonyl}-6-(tetrazol-5-yl)spiro[chroman-2,4'-piperidin]-4-one

HRID 1096903ノート

反応式

HRID 1096903 の反応式
C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[CH3:23][C:24]1[O:25][C:26]([C:29]2[C:37]([O:38][CH3:39])=[CH:36][C:32]([C:33]([OH:35])=O)=[CH:31][C:30]=2[O:40][CH3:41])=[CH:27][N:28]=1.Cl.[NH:43]1[C:47]([C:48]2[CH:49]=[C:50]3[C:60](=[CH:61][CH:62]=2)[O:59][C:53]2([CH2:58][CH2:57][NH:56][CH2:55][CH2:54]2)[CH2:52][C:51]3=[O:63])=[N:46][N:45]=[N:44]1>O.CN(C=O)C.CCN(CC)CC>[CH3:23][C:24]1[O:25][C:26]([C:29]2[C:30]([O:40][CH3:41])=[CH:31][C:32]([C:33]([N:56]3[CH2:57][CH2:58][C:53]4([CH2:52][C:51](=[O:63])[C:50]5[C:60](=[CH:61][CH:62]=[C:48]([C:47]6[NH:46][N:45]=[N:44][N:43]=6)[CH:49]=5)[O:59]4)[CH2:54][CH2:55]3)=[O:35])=[CH:36][C:37]=2[O:38][CH3:39])=[CH:27][N:28]=1

参加物

8

実験手順

Et3N (28 μL), HOBT (15 mg) and WSC hydrochloride (19 mg) were added to a DMF (3 mL) solution of 4-(2-methyl-1,3-oxazol-5-yl)-3,5-dimethoxybenzoic acid (22 mg) and 6-(tetrazol-5-yl)spiro[chroman-2,4′-piperidin]-4-one hydrochloride (32 mg), and stirred overnight at room temperature. Water was added to the reaction liquid, the formed solid was taken out through filtration, and the solid was washed with water and ether. The solid was dried under reduced pressure to obtain the title compound. 1H-NMR (400 MHz, DMSO-d6) δ: 8.42 (1H, d, J=4.0 Hz), 8.23 (1H, dd, J=8.0, 4.0 Hz), 7.32 (1H, d, J=8.0 Hz), 7.08 (1H, s), 6.75 (2H, s), 4.32-4.18 (1H, m), 3.79 (6H, s), 3.64-3.20 (3H, m), 2.97 (2H, s), 2.41 (3H, s), 2.10-1.75 (4H, m). MS [M+H]+=531.

後処理

  1. filtrationthe formed solid was taken out through filtration
  2. washthe solid was washed with water and ether
  3. customThe solid was dried under reduced pressure

出典と根拠

ORDレコード
ord-fc3d1a0216b34257a1ceb544889ee1df
出典データセット
uspto-grants-2012_03
特許番号
US08138197B2

反応ノート

読み込み中…